I have just finished reading into Qbotics product, EBC-46. I am no expert however and just want state what I have understood from reading and listening to their media.
Seems this tech is also based on an "immune" response from the body, although somewhat more targeted via direct injection to a solid tumor.
It is interesting that this "immune" response technology is somewhat "fashionable" in terms of cancer therapies and have reduced or non-existant side-affects on the body. A huge plus when it comes to clinical testing I would say. Now it has passed FDA approval in USA via DNDN so its no joke and a serious advance.
So, I see this as a similar avenue to PRR in terms of immunotherapies, however PRR is well advanced to nearly starting the final stage 3. QBiotics have not yet started human testing. One can only speculate at this early although significant stage. I agree there is "no concern here" in terms of investing in PRR.
It is interesting QBiotics are open about wanting to sell their company to a major after stage 2 human testing results are complete.
QBiotics MC will be 50-60mil after the current cap raising which is before embarking on human testing, so are well priced relative to PRR, or PRR are well undervalued, so I suspect PRR could be re-rated on this news. This is good news for PRR.
- Forums
- ASX - By Stock
- IMM
- no need to be concerned
no need to be concerned, page-7
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $458.1M |
Open | High | Low | Value | Volume |
32.0¢ | 32.8¢ | 31.0¢ | $1.817M | 5.763M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 71665 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 36363 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 71665 | 0.310 |
17 | 336339 | 0.305 |
21 | 385559 | 0.300 |
4 | 79250 | 0.295 |
8 | 215108 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 36363 | 2 |
0.325 | 297337 | 6 |
0.330 | 97094 | 5 |
0.335 | 164962 | 3 |
0.340 | 110101 | 4 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online